- Stocks
- Pharma & Healthcare
- Zota Health Care
Zota Health Care share price
NSE: ZOTAPharma & HealthcareBiotechnology
Zota Health Care at a glance
Zota Health Care (NSE: ZOTA) closed at ₹1,304.00 on 22 Oct 2026, down 0.76% on the day. With a market capitalisation of ₹4,516 Cr, it ranks 820th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Biotechnology.
Its return on equity was −10.7% in FY26. Over the past year the share price has fallen 12.1%. Its 52-week range is ₹1,022.00 (2 Sep 2026) to ₹1,740.00 (21 Nov 2025); the last close is 25.1% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹163 Cr (+67.8% year on year) and net profit −₹14 Cr, on a consolidated basis. Promoters held 49.38% of the company as of 30 Jun 2026; 0.26% of promoter shares were pledged.
Key numbers
- Market cap
- ₹4,516 CrRank 820 on NSE
- Price to book
- 5.32×FY26
- EPS (TTM)
- −₹23.75to Q4 FY26
- ROE
- −10.7%FY26
- ROCE
- −6.3%FY26
- Debt to equity
- 0.04FY26
- Net profit margin
- −13.8%FY26
- Book value / share
- ₹200.24FY26
- 52-week high
- ₹1,740.0021 Nov 2025
- 52-week low
- ₹1,022.002 Sep 2026
- 1-year return
- −12.1%
- RSI (14-day)
- 51.5
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.76% | −8.2% | −0.5% | +2.3% | −12.1% |
Zota Health Care quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹56 Cr | ₹67 Cr | ₹72 Cr | ₹97 Cr | ₹104 Cr | ₹129 Cr | ₹143 Cr | ₹163 Cr |
| Revenue YoY | +45.7% | +48.6% | +53.7% | +96.0% | +84.0% | +91.7% | +98.2% | +67.8% |
| Net profit | −₹13 Cr | −₹12 Cr | −₹19 Cr | −₹13 Cr | −₹14 Cr | −₹16 Cr | −₹30 Cr | −₹14 Cr |
| Net profit YoY | — | — | — | — | — | — | — | — |
| Net margin | −22.6% | −18.1% | −26.3% | −13.3% | −13.3% | −12.6% | −20.7% | −8.9% |
| EPS | −₹4.80 | −₹4.57 | −₹6.80 | −₹4.57 | −₹4.92 | −₹5.26 | −₹9.44 | −₹4.13 |
Zota Health Care financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹107 Cr | ₹131 Cr | ₹140 Cr | ₹180 Cr | ₹293 Cr | — |
| Operating profit | −₹1 Cr | ₹12 Cr | −₹5 Cr | −₹16 Cr | −₹58 Cr | — |
| Net profit | −₹0 Cr | ₹9 Cr | −₹6 Cr | −₹14 Cr | −₹57 Cr | — |
| EPS (₹) | ₹0.00 | ₹4.00 | −₹2.00 | −₹6.00 | −₹21.00 | — |
| Cash from operations | −₹1 Cr | ₹13 Cr | −₹2 Cr | −₹6 Cr | −₹50 Cr | — |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹6 Cr |
| Shareholders' equity | ₹66 Cr | ₹90 Cr | ₹80 Cr | ₹90 Cr | ₹224 Cr | ₹693 Cr |
Zota Health Care shareholding pattern
| Holder | 30 Jun 2025 | 30 Sep 2025 | 17 Dec 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 57.42% | 55.81% | 51.56% | 50.64% | 49.38% | 49.38% |
| Foreign institutions | 3.82% | 3.49% | 8.00% | 8.09% | 8.21% | 7.92% |
| Domestic institutions | 4.25% | 4.95% | 6.09% | 7.22% | 6.40% | 6.75% |
| Non-institutions | 34.52% | 35.75% | 34.35% | 34.06% | 36.00% | 35.96% |
| Promoter shares pledged | 0.26% | 0.26% | — | 0.26% | 0.26% | 0.26% |
Zota Health Care vs peers
The listed Pharma & Healthcare companies nearest to Zota Health Care by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| IOLCPIOL Chemicals and Pharmaceuticals | ₹173.27 | −0.76% | +80.5% | ₹5,086 Cr | 36.9 | — |
| RPGLIFERPG Life Sciences | ₹2,754.80 | −2.31% | +18.9% | ₹4,556 Cr | 39.6 | — |
| ZOTAZota Health Care | ₹1,304.00 | −0.76% | −12.1% | ₹4,516 Cr | — | — |
| JSLLJeena Sikho Lifecare | ₹360.05 | −0.40% | −51.3% | ₹4,475 Cr | 20.3 | — |
| NOVARTINDNovartis India | ₹1,810.70 | +2.71% | +224.4% | ₹4,471 Cr | 48 | — |
| ORCHPHARMAOrchid Pharma | ₹876.25 | +0.06% | +20.9% | ₹4,444 Cr | 214.2 | — |
| SMSPHARMASMS Pharmaceuticals | ₹434.55 | +0.59% | +59.0% | ₹4,070 Cr | 39 | — |
Ask anything about Zota Health Care
Pivot answers on the live chart with evidence you can check, and tests strategies against ZOTA's own history. Try: “Why has ZOTA moved over the last three months?” · “Backtest a 50-day moving-average crossover on ZOTA over five years” · “Compare ZOTA with IOLCP on margins and valuation”
Frequently asked questions about Zota Health Care
What is the share price of Zota Health Care today?
Zota Health Care (NSE: ZOTA) last closed at ₹1,304.00 on 22 Oct 2026. Its 52-week high is ₹1,740.00 and its 52-week low is ₹1,022.00.
What is the market cap of Zota Health Care?
Zota Health Care's market capitalisation is ₹4,516 Cr (₹4,516 Cr) at the 22 Oct 2026 close, ranking 820th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Zota Health Care?
Return on equity was −10.7% in FY26 and return on capital employed was −6.3% in FY26 (consolidated figures).
Is Zota Health Care a debt-free company?
Zota Health Care is close to debt-free: its debt-to-equity ratio was 0.04 in FY26.
What were Zota Health Care's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Zota Health Care reported revenue of ₹163 Cr, +67.8% year on year, and net profit of −₹14 Cr.
How has Zota Health Care stock performed over the last year?
Zota Health Care's share price has fallen 12.1% over the past year, +2.3% over three months and −0.5% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Zota Health Care?
As of 30 Jun 2026: promoters 49.38%, foreign institutions 7.92%, domestic institutions 6.75%, non-institutions 35.96%. 0.26% of promoter shares were pledged.
Who are Zota Health Care's competitors?
The listed Pharma & Healthcare companies closest to Zota Health Care by market cap are IOL Chemicals and Pharmaceuticals, RPG Life Sciences, Jeena Sikho Lifecare, Novartis India, Orchid Pharma and SMS Pharmaceuticals.
Is Zota Health Care a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Zota Health Care's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ZOTA against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with Z · all NSE stocks · this page as text